Results 1 to 10 of about 79,184 (165)
Global, Regional, and National Burden of CKD due to Glomerulonephritis from 1990 to 2019
American Society of Nephrology. Clinical Journal, 2022 Visual Abstract Background CKD is becoming a major human health concern. Limited quantitative assessments of the burden of CKD due to glomerulonephritis have been performed.
Ju-Lan Hu +8 more
semanticscholar +1 more source
Glomerulonephritis: immunopathogenesis and immunotherapy
Nature reviews. Immunology, 2023 ‘Glomerulonephritis’ (GN) is a term used to describe a group of heterogeneous immune-mediated disorders characterized by inflammation of the filtration units of the kidney (the glomeruli).
H. Anders +3 more
semanticscholar +1 more source
COVID-19 Vaccination and Glomerulonephritis
Kidney International Reports, 2021 Introduction mRNA COVID-19 vaccine is more effective than traditional vaccines owing to superior immune activation. Nevertheless, the impact of mRNA COVID-19 vaccine on triggering de novo/relapsing glomerulonephritis (GN) is limited.
N. Klomjit +8 more
semanticscholar +1 more source
Definitions, 2020 A histopathologic term for a pattern of diseases characterized by extensive crescent formation in the glomeruli; patients present clinically with rapid deterioration of renal function, and possible progression to end-stage renal failure within weeks or ...
semanticscholar +1 more source
Development and validation of a renal risk score in ANCA-associated glomerulonephritis.
Kidney International, 2018 Predicting renal outcome in antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis (GN) remains a major challenge. We aimed to identify reliable predictors of end-stage renal disease (ESRD) and to develop and validate a ...
S. Brix +16 more
semanticscholar +1 more source
Glomerulonephritis Histopathological Pattern Change
BMC Nephrology, 2020 Background Glomerulonephritides (GN) are relatively rare kidney diseases with substantial morbidity and mortality. They are often difficult to treat, sometimes with no cure, and can lead to chronic kidney disease (CKD) and end stage kidney disease (ESKD).
A. Alyousef +7 more
semanticscholar +1 more source
Fibrillary Glomerulonephritis: An Update
Kidney International Reports, 2019 Fibrillary glomerulonephritis (FGN) is a rare proliferative form of glomerular disease characterized by randomly oriented fibrillar deposits with a mean diameter of 20 nm.
J. Rosenstock, G. Markowitz
semanticscholar +1 more source
New developments in the diagnosis of fibrillary glomerulonephritis.
Kidney International, 2019 Fibrillary glomerulonephritis is a glomerular disease historically defined by glomerular deposition of Congo red-negative, randomly oriented straight fibrils that lack a hollow center and stain with antisera to immunoglobulins.
S. Nasr, A. Fogo
semanticscholar +1 more source
Nature Communications, 2017 Mesangial cells-mediated glomerulonephritis is a frequent cause of end-stage renal disease. Here, we show that celastrol is effective in treating both reversible and irreversible mesangioproliferative glomerulonephritis in rat models, but find that its ...
Ling Guo +8 more
semanticscholar +1 more source
CTGF in kidney fibrosis and glomerulonephritis
Inflammation and Regeneration, 2018 Glomerulonephritis, which causes inflammation in glomeruli, is a common cause of end-stage renal failure. Severe and prolonged inflammation can damage glomeruli and lead to kidney fibrosis.
Naohiro Toda +3 more
semanticscholar +1 more source